UConn Health Logo Health


Brenton R. Graveley, Ph.D.

Welcome to the Department of Genetics and Genome Sciences. Created in 1998, the department offers many exciting opportunities for research and graduate education. The department is located in the state-of-the-art Cell and Genome Sciences Building. The department is also the academic home of the Division of Medical Genetics which provides clinical and laboratory genetics services to Connecticut. Our research strengths include RNA biology, developmental biology, signal transduction, and the genetic and epigenetic mechanisms of gene regulation. We are continually increasing external funding for our current research programs, enhancing the national and international reputation of our faculty and their research, and recruiting outstanding faculty members with new and complementary areas of research expertise. We also have a close working relationship with the Jackson Laboratory for Genomic Medicine (JAX-GM), and most JAX-GM faculty have academic appointments in our department. 
Dr. Brenton R. Graveley, Professor and Chair of Genetics and Genome Sciences, UConn School of Medicine, and Endowed Chair, Genomics and Personalized Healthcare; Director, UConn Stem Cell Institute and Associate Director, Institute for System Genomics, University of Connecticut.

Tenure-Track Faculty Position

The Department invites applications for a tenure-track faculty position at the Assistant/Associate Professor level (position #2019-069). Successful applicants will have the opportunity to participate in a highly interactive culture within the Department, with our close colleagues at The Jackson Laboratory, and the UConn Institute for Systems Genomics. The ideal candidate is expected to complement existing strengths in the department with an robust research program focused on a cutting-edge area of contemporary genetics and/or genomics. Areas of interest include, but are not limited to single-cell genomics, RNA genomics, epigenetics, genome editing and engineering, synthetic genomics, genome technology, and computational genomics.

Gordon Carmichael inducted into CASE

Gordon G. Carmichael, Ph.D.Professor Gordon Carmichael has been inducted into the 2018 Connecticut Academy of Science and Engineering (CASE) for his pioneering contributions to the field of RNA biology in mammalian cells and their viruses. His work has provided key insights into the mechanisms of splicing, polyadenylation and RNA export from the nucleus to the cytoplasm, as well as the mechanism of action of naturally-occurring antisense RNA regulations and RNA editing.

Next Generation Venture Capitalist Training at UConn School of Medicine

Blanka Rogina, Ph.D., was appointed by  Dr. Bruce Liang, Dean of the UConn School of Medicine, to Chair the UConn-Canaan Fellowship Program Committee. This program provides our students hands-on training for  real life, venture capital projects. (read more)

Noelle Germain receives award to study Angelman Syndrome

Noelle Germain, a postdoctoral research fellow in the department of genetics and genome sciences at UConn Health has received a fellowship from the Angelman Syndrome Foundation to investigate two novel approaches to reversing the abnormal genetic expression that causes the rare genetic disease (read full article).

Raising Awareness about Rare Diseases

Stormy Chamberlain, associate professor of genetics and genome sciences, speaks at the Connecticut Rare Disease Day on February 28, 2018.  Chamberlain’s research focuses on three rare diseases affecting children: Prader-Willi syndrome, 15q duplication syndrome and Angelman syndrome. She was joined by Jim Kubicza, director of the Angelman Syndrome Foundation and father of a child suffering from the condition (read full article).

Inaugural Fellow, UConn-Canaan Fellowship Program

Congratulations to Scott Adamson who was selected to participate in the UConn-Canaan Fellowship Program. Students selected receive hands-on training from Canaan Partners, a multi-billion dollar venture capital firm. Scott is currently a Ph.D. student in the Graveley lab. His research focuses on developing and utilizing high-throughput reporter assays in order to study the genetic variants can impact pre-mRNA splicing.